Actions and Detail Panel
Eliminating Silos: Enabling Engagement Across the Value Chain
Tue, May 16, 2017, 4:00 PM – 7:00 PM EDT
The verticalization of drug development has long prohibited companies from taking a true end-to-end view of the development cycle. But eliminating these functional silos can enable sharper customer focus while also reducing development time, costs, and resource requirements.
TayganPoint explores this topic through a variety of functional lenses - including points of view from Clinical Development, Supply Chain, and Sales & Marketing. In addition, we'll discuss the various pressures and industry trends prompting companies to consider a more horizontally integrated approach. We hope you can join us!
4:00pm | Pre-Event Happy Hour
5:00pm | Panel Discussion and Breakout Sessions
6:30pm | Cocktails and Networking
VP Clinical Development Operations | CSL Behring
BRIAN H. LANGE, P.E.
Associate VP Supply Chain Management | Merck & Co.
Former VP, Mature Brands and Global Commercial Excellence | AstraZeneca